Similar articles for PMID: 26546654

Year	Number of Results
1996	2
1999	1
2002	2
2004	1
2005	1
2006	3
2007	2
2008	2
2009	3
2010	3
2011	3
2012	11
2013	6
2014	8
2015	8
2016	5
2017	2
2018	1
2019	4
2021	1

1

Variations in Metformin Prescribing for Type 2 Diabetes.

Goldberg T, Kroehl ME, Suddarth KH, Trinkley KE. Goldberg T, et al. J Am Board Fam Med. 2015 Nov-Dec;28(6):777-84. doi: 10.3122/jabfm.2015.06.150064. J Am Board Fam Med. 2015. PMID: 26546654 Free article.

2

Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.

del Pozo-Fernández C, Pardo-Ruiz C, Sánchez-Botella C, Blanes-Castañer V, López-Menchero R, Gisbert-Sellés C, Sánchez-Jodar C, Alvarez-Avellán L. del Pozo-Fernández C, et al. Nefrologia. 2012 May 14;32(3):367-73. doi: 10.3265/Nefrologia.pre2012.Jan.11244. Nefrologia. 2012. PMID: 22592422 Free article. English, Spanish.

3

Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.

Altun E, Kaya B, Paydaş S, Sarıakçalı B, Karayaylalı I. Altun E, et al. Hemodial Int. 2014 Apr;18(2):529-31. doi: 10.1111/hdi.12109. Epub 2013 Dec 3. Hemodial Int. 2014. PMID: 24299454

4

[Proposal for the modification of metformin use in patients with chronic kidney disease].

Balogh Z, Mátyus J. Balogh Z, et al. Orv Hetil. 2012 Sep 30;153(39):1527-35. doi: 10.1556/OH.2012.29448. Orv Hetil. 2012. PMID: 23000419 Review. Hungarian.

5

Do risk factors for lactic acidosis influence dosing of metformin?

Millican S, Cottrell N, Green B. Millican S, et al. J Clin Pharm Ther. 2004 Oct;29(5):449-54. doi: 10.1111/j.1365-2710.2004.00589.x. J Clin Pharm Ther. 2004. PMID: 15482389

6

Metformin-associated lactic acidosis treated with continuous renal replacement therapy.

Alivanis P, Giannikouris I, Paliuras C, Arvanitis A, Volanaki M, Zervos A. Alivanis P, et al. Clin Ther. 2006 Mar;28(3):396-400. doi: 10.1016/j.clinthera.2006.03.004. Clin Ther. 2006. PMID: 16750454

7

Balancing risk and benefit with oral hypoglycemic drugs.

Hamnvik OP, McMahon GT. Hamnvik OP, et al. Mt Sinai J Med. 2009 Jun;76(3):234-43. doi: 10.1002/msj.20116. Mt Sinai J Med. 2009. PMID: 19421967

8

Limitations of metformin use in patients with kidney disease: are they warranted?

Vasisht KP, Chen SC, Peng Y, Bakris GL. Vasisht KP, et al. Diabetes Obes Metab. 2010 Dec;12(12):1079-83. doi: 10.1111/j.1463-1326.2010.01295.x. Diabetes Obes Metab. 2010. PMID: 20977579

9

Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group study.

Trinkley KE, Malone DC, Nelson JA, Saseen JJ. Trinkley KE, et al. Ther Adv Chronic Dis. 2016 Sep;7(5):220-8. doi: 10.1177/2040622316657328. Epub 2016 Aug 11. Ther Adv Chronic Dis. 2016. PMID: 27583122 Free PMC article.

10

A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure.

Adam WR, O'Brien RC. Adam WR, et al. Diabet Med. 2014 Sep;31(9):1032-8. doi: 10.1111/dme.12515. Diabet Med. 2014. PMID: 24909998 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed